Natia Horato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natia Horato has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Egidio Nardi
Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
16 shared publications - Laiana Azevedo Quagliato
Child and Adolescent Psychiatry Laboratory, Psychiatry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
9 shared publications - Pablo Eduardo Pereira Dutra
Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro (LABPR/IPUB/UFRJ), Rio de Janeiro, Brazil
6 shared publications - Felipe Dalvi-Garcia
Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
5 shared publications - Alana Tercino Frias
Department of Animal Morphology and Physiology São Paulo State University – UNESP/FCAV Jaboticabal São Paulo Brazil
2 shared publications - Amanda Cardoso
Institute of Psychiatry, Laboratory of Panic and Respiration, Federal University of Rio de Janeiro, Rio de Janeiro RJ, Rio de Janeiro, Brazil
2 shared publications
Latest Publications
- Open Access
- 13 October 2026
- Published by Bentham Science Publishers Ltd. in Clinical Practice & Epidemiology in Mental Health
- Vol. 22 (1)
Franco Basaglia at 100: Human Rights and the Transformation of Psychiatry
Franco Basaglia's centenary, celebrated on March 11, 2024, invites reflection on the historical significance of his legacy. His work in defense of people with mental disorders represents his fight for the protection of human dignity and the value of life. Pejoratively called “the philosopher Basaglia,” he transformed psychiatric practices by pushing the boundaries of medicine to address profound human rights issues. Basaglia adopted an existential-analytical stance that underpinned his commitment to psychiatric reform and the management of mental health practice, inspiring changes in public policies around the world. This commemorative editorial presents a historical overview of Franco Basaglia's contributions to psychiatric reform and their implications for mental health care.
- 13 October 2026
- Published by Bentham Science Publishers Ltd. in Clinical Practice & Epidemiology in Mental Health
- Vol. 22 (1)
Open AccessFranco Basaglia at 100: Human Rights and the Transformation of Psychiatry
Franco Basaglia's centenary, celebrated on March 11, 2024, invites reflection on the historical significance of his legacy. His work in defense of people with mental disorders represents his fight for the protection of human dignity and the value of life. Pejoratively called “the philosopher Basaglia,” he transformed psychiatric practices by pushing the boundaries of medicine to address profound human rights issues. Basaglia adopted an existential-analytical stance that underpinned his commitment to psychiatric reform and the management of mental health practice, inspiring changes in public policies around the world. This commemorative editorial presents a historical overview of Franco Basaglia's contributions to psychiatric reform and their implications for mental health care.
- 27 July 2026
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 46 (5) , 656
Reply to “Reading the Signal: What Psychedelic Trials in Depression Still Can’t Tell Us”
Was not provided for this article.
- 27 July 2026
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 46 (5) , 656
Reply to “Reading the Signal: What Psychedelic Trials in Depression Still Can’t Tell Us”
Was not provided for this article.
- Open Access
- 3 February 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Minocycline attenuates panicogenic responses in a CO2-induced panic attack model: a translational approach
There is a connection between neuroinflammation and panic attacks (PA), as microglia-driven pro-inflammatory responses help detect homeostatic disturbances like CO₂ inhalation. This model has become widely used in research since CO₂ exposure can trigger PA in humans and panic-related behavior in mice. Minocycline inhibits microglia activation, serving as a promising tool to attenuate CO2-induced PA. The locus coeruleus (LC) is a CO₂/pH-sensitive region, and disruptions in its activity are linked to psychiatric conditions such as panic disorder (PD). We investigated the involvement of microglia in the respiratory and behavioral responses induced by CO2 in mice and the effect of minocycline and clonazepam treatment. We also assessed in mice whether LC microglia are activated after hypercapnia using IBA-1 immunohistochemistry. Translationally, PD patients were treated with minocycline and clonazepam and examined for their CO2-responsiveness. LC microglia were activated 6 h after exposure to 20% CO2 in mice. This panicogenic stimulus also induced hyperventilation as well as active panic-related escape responses, characterized by jumps and running episodes. Minocycline and clonazepam decreased escape expression during the CO2 challenge, but only the former drug reduced hyperventilatory responses. None of the drugs changed IL levels in LC. In humans, minocycline reduced the severity of CO2-induced panic attacks and also modulated the immune response by lowering IL-2sRα and increasing IL-10 levels. Exposure to hypercapnia activates microglia in the LC of mice. Treatment with minocycline, similar to the clinically effective panicolytic clonazepam, attenuates CO2-induced panic-like responses in both mice and humans. These results support the potential of minocycline as a therapeutic strategy for PD.
- 3 February 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessMinocycline attenuates panicogenic responses in a CO2-induced panic attack model: a translational approach
There is a connection between neuroinflammation and panic attacks (PA), as microglia-driven pro-inflammatory responses help detect homeostatic disturbances like CO₂ inhalation. This model has become widely used in research since CO₂ exposure can trigger PA in humans and panic-related behavior in mice. Minocycline inhibits microglia activation, serving as a promising tool to attenuate CO2-induced PA. The locus coeruleus (LC) is a CO₂/pH-sensitive region, and disruptions in its activity are linked to psychiatric conditions such as panic disorder (PD). We investigated the involvement of microglia in the respiratory and behavioral responses induced by CO2 in mice and the effect of minocycline and clonazepam treatment. We also assessed in mice whether LC microglia are activated after hypercapnia using IBA-1 immunohistochemistry. Translationally, PD patients were treated with minocycline and clonazepam and examined for their CO2-responsiveness. LC microglia were activated 6 h after exposure to 20% CO2 in mice. This panicogenic stimulus also induced hyperventilation as well as active panic-related escape responses, characterized by jumps and running episodes. Minocycline and clonazepam decreased escape expression during the CO2 challenge, but only the former drug reduced hyperventilatory responses. None of the drugs changed IL levels in LC. In humans, minocycline reduced the severity of CO2-induced panic attacks and also modulated the immune response by lowering IL-2sRα and increasing IL-10 levels. Exposure to hypercapnia activates microglia in the LC of mice. Treatment with minocycline, similar to the clinically effective panicolytic clonazepam, attenuates CO2-induced panic-like responses in both mice and humans. These results support the potential of minocycline as a therapeutic strategy for PD.
- 12 January 2026
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 46 (2) , 195-206
The Therapeutic Potential of Psychedelics for Treatment-resistant Depression
Background: Treatment-resistant depression (TRD), a clinical subtype of major depressive disorder (MDD), is associated with greater severity and functional impairment, representing a significant challenge in psychiatric care. Recent studies suggest that the use of psychedelics can provide rapid and substantial improvement in the severity of depressive symptoms. Therefore, the aim of this systematic review is to evaluate and synthesize the evidence on the efficacy of psychedelics in the treatment of TRD. Methods: Studies were included if they enrolled participants diagnosed with TRD, used scales to assess depression severity, reported effect sizes or provided metrics for calculating effect sizes of the intervention, and involved single-blind, double-blind, or open-label trials, including single-arm studies. Results: Fifteen articles were included in this systematic review, 10 of which were randomized double-blind controlled trials (RCTs) and 5 open-label clinical trials. All studies were summarized and analyzed, providing a current overview of the scientific literature on the therapeutic potential of typical and atypical psychedelics in TRD. Conclusions: The use of psychedelics in the treatment of treatment-resistant depression represents an alternative and complementary therapeutic approach to traditional treatments, suggesting efficacy across different classes of these substances.
- 12 January 2026
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 46 (2) , 195-206
The Therapeutic Potential of Psychedelics for Treatment-resistant Depression
Background: Treatment-resistant depression (TRD), a clinical subtype of major depressive disorder (MDD), is associated with greater severity and functional impairment, representing a significant challenge in psychiatric care. Recent studies suggest that the use of psychedelics can provide rapid and substantial improvement in the severity of depressive symptoms. Therefore, the aim of this systematic review is to evaluate and synthesize the evidence on the efficacy of psychedelics in the treatment of TRD. Methods: Studies were included if they enrolled participants diagnosed with TRD, used scales to assess depression severity, reported effect sizes or provided metrics for calculating effect sizes of the intervention, and involved single-blind, double-blind, or open-label trials, including single-arm studies. Results: Fifteen articles were included in this systematic review, 10 of which were randomized double-blind controlled trials (RCTs) and 5 open-label clinical trials. All studies were summarized and analyzed, providing a current overview of the scientific literature on the therapeutic potential of typical and atypical psychedelics in TRD. Conclusions: The use of psychedelics in the treatment of treatment-resistant depression represents an alternative and complementary therapeutic approach to traditional treatments, suggesting efficacy across different classes of these substances.
- Open Access
- 1 January 2026
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- p. 1-7
Thirty Years of the Laboratory of Panic and Respiration: From Respiratory Panic to Translational Psychiatry
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- 1 January 2026
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- p. 1-7
Open AccessThirty Years of the Laboratory of Panic and Respiration: From Respiratory Panic to Translational Psychiatry
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- 1 January 2026
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
Unrecognized Even in Death: The Statistical Invisibility of Autistic People in Brazilian Suicide Mortality Records
Suicide is a leading cause of premature death in Brazil. Some groups are at higher risk of committing suicide, including individuals with Autism Spectrum Disorder (ASD). This study aimed to assess whether autistic people are being identified in Brazilian official mortality records and whether this condition is being acknowledged as a contributing factor to suicide. We assessed a standardized version of the Brazilian Mortality Information System (SIM), filtering deaths by suicide from 1996 to 2024 in which the underlying cause of death was intentional self-harm, sequelae of intentional self-harm, or undetermined intent possibly due to self-harm. Variables potentially indicating contributing conditions related to ASD or intellectual disability (ID) were examined. Of 579,121 deaths by suicide, only 81 certificates recorded ASD or ID, and only 16 recognized autistic people. Fifteen were men, with a mean age 33.5 ± 17.2 years. The first certificate listing ID was in 2000; the first mentioning autism was not until 2008. Our findings suggest under-reporting of ASD as a factor relevant to suicide and a substantial disparity compared to other countries' statistics. Improving certifying professional training and integrating datasets may enhance suicide prevention efforts for people with neurodevelopmental conditions.
- 1 January 2026
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
Unrecognized Even in Death: The Statistical Invisibility of Autistic People in Brazilian Suicide Mortality Records
Suicide is a leading cause of premature death in Brazil. Some groups are at higher risk of committing suicide, including individuals with Autism Spectrum Disorder (ASD). This study aimed to assess whether autistic people are being identified in Brazilian official mortality records and whether this condition is being acknowledged as a contributing factor to suicide. We assessed a standardized version of the Brazilian Mortality Information System (SIM), filtering deaths by suicide from 1996 to 2024 in which the underlying cause of death was intentional self-harm, sequelae of intentional self-harm, or undetermined intent possibly due to self-harm. Variables potentially indicating contributing conditions related to ASD or intellectual disability (ID) were examined. Of 579,121 deaths by suicide, only 81 certificates recorded ASD or ID, and only 16 recognized autistic people. Fifteen were men, with a mean age 33.5 ± 17.2 years. The first certificate listing ID was in 2000; the first mentioning autism was not until 2008. Our findings suggest under-reporting of ASD as a factor relevant to suicide and a substantial disparity compared to other countries' statistics. Improving certifying professional training and integrating datasets may enhance suicide prevention efforts for people with neurodevelopmental conditions.
- Open Access
Minocycline attenuates panicogenic responses in a CO ₂ -induced panic attack model: a translational approach
There is a connection between neuroinflammation and panic attacks (PA), as microglia-driven pro-inflammatory responses help detect homeostatic disturbances like CO ₂ inhalation. This model has become widely used in research since CO ₂ exposure can trigger PA in humans and panic-related behavior in mice. Minocycline inhibits microglia activation, serving as a promising tool to attenuate CO 2 -induced PA. The locus coeruleus (LC) is a CO ₂ /pH-sensitive region, and disruptions in its activity are linked to psychiatric conditions such as panic disorder (PD). We investigated the involvement of microglia in the respiratory and behavioral responses induced by CO 2 in mice and the effect of minocycline and clonazepam treatment. We also assessed in mice whether LC microglia are activated after hypercapnia using IBA-1 immunohistochemistry. Translationally, PD patients were treated with minocycline and clonazepam and examined for their CO 2 -responsiveness. LC microglia were activated 6 hours after exposure to 20% CO 2 in mice. This panicogenic stimulus also induced hyperventilation as well as active panic-related escape responses, characterized by jumps and running episodes. Minocycline and clonazepam decreased escape expression during the CO 2 challenge, but only the former drug reduced hyperventilatory responses. None of the drugs changed IL levels in LC. In humans, minocycline reduced the severity of CO 2 -induced panic attacks and also modulated the immune response by lowering IL-2sRα and increasing IL-10 levels. Exposure to hypercapnia activates microglia in the LC of mice. Treatment with minocycline, similar to the clinically effective panicolytic clonazepam, attenuates CO 2 -induced panic-like responses in both mice and humans. These results support the potential of minocycline as a therapeutic strategy for PD.
Open AccessMinocycline attenuates panicogenic responses in a CO ₂ -induced panic attack model: a translational approach
There is a connection between neuroinflammation and panic attacks (PA), as microglia-driven pro-inflammatory responses help detect homeostatic disturbances like CO ₂ inhalation. This model has become widely used in research since CO ₂ exposure can trigger PA in humans and panic-related behavior in mice. Minocycline inhibits microglia activation, serving as a promising tool to attenuate CO 2 -induced PA. The locus coeruleus (LC) is a CO ₂ /pH-sensitive region, and disruptions in its activity are linked to psychiatric conditions such as panic disorder (PD). We investigated the involvement of microglia in the respiratory and behavioral responses induced by CO 2 in mice and the effect of minocycline and clonazepam treatment. We also assessed in mice whether LC microglia are activated after hypercapnia using IBA-1 immunohistochemistry. Translationally, PD patients were treated with minocycline and clonazepam and examined for their CO 2 -responsiveness. LC microglia were activated 6 hours after exposure to 20% CO 2 in mice. This panicogenic stimulus also induced hyperventilation as well as active panic-related escape responses, characterized by jumps and running episodes. Minocycline and clonazepam decreased escape expression during the CO 2 challenge, but only the former drug reduced hyperventilatory responses. None of the drugs changed IL levels in LC. In humans, minocycline reduced the severity of CO 2 -induced panic attacks and also modulated the immune response by lowering IL-2sRα and increasing IL-10 levels. Exposure to hypercapnia activates microglia in the LC of mice. Treatment with minocycline, similar to the clinically effective panicolytic clonazepam, attenuates CO 2 -induced panic-like responses in both mice and humans. These results support the potential of minocycline as a therapeutic strategy for PD.
- Open Access
- 26 March 2025
- Published by Springer Nature in BMC Psychology
- Vol. 13 (1) , 1-21
Could the use of web-based applications assist in neuropsychiatric treatment? An umbrella review
The aim of this study was to evaluate the use of applications accessed through internet browsers as tools for neuropsychiatric treatment, as well as to verify the benefits and efficacy of virtual support as a therapeutic approach. A broad review of the MEDLINE (PubMed), SciELE and Cochrane databases for review articles was conducted. Articles involving the use of browser-based applications as a support for neurological and psychiatric treatment, with available texts on the selected platforms with no language or year restrictions, were included. A total of 83 reviews were included in this study. Due to the homogeneity of the information between some articles, the research was grouped according to the following revised themes: mindfulness, tinnitus, electronic health (eHealth), youth and students’ mental health, mobile health applications (mHealth), depression, anxiety and stress, psychoactive substances, sleep quality, chronic diseases and mental disorders. The findings suggest that the use of virtual support through applications helps neuropsychiatric treatment, improving the well-being and quality of life of these patients.
- 26 March 2025
- Published by Springer Nature in BMC Psychology
- Vol. 13 (1) , 1-21
Open AccessCould the use of web-based applications assist in neuropsychiatric treatment? An umbrella review
The aim of this study was to evaluate the use of applications accessed through internet browsers as tools for neuropsychiatric treatment, as well as to verify the benefits and efficacy of virtual support as a therapeutic approach. A broad review of the MEDLINE (PubMed), SciELE and Cochrane databases for review articles was conducted. Articles involving the use of browser-based applications as a support for neurological and psychiatric treatment, with available texts on the selected platforms with no language or year restrictions, were included. A total of 83 reviews were included in this study. Due to the homogeneity of the information between some articles, the research was grouped according to the following revised themes: mindfulness, tinnitus, electronic health (eHealth), youth and students’ mental health, mobile health applications (mHealth), depression, anxiety and stress, psychoactive substances, sleep quality, chronic diseases and mental disorders. The findings suggest that the use of virtual support through applications helps neuropsychiatric treatment, improving the well-being and quality of life of these patients.
- 3 March 2025
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 42 (3) , 170-174
Use of Electroconvulsive Therapy in a University Psychiatric Hospital in Brazil
Objectives: The aim of the study were to describe the practice of electroconvulsive therapy (ECT) at the Institute of Psychiatry (IPUB) of the Federal University of Rio de Janeiro (UFRJ) from 2015 to 2019 and to compare it with previous years at the same institute and with international practices. Methods: Sociodemographic and epidemiological data, along with information on ECT and anesthetic techniques, were collected from the medical records of all patients who received ECT at IPUB-UFRJ between 2015 and 2019. Results: A total of 238 patients underwent 4110 ECT sessions during the study period. A slight predominance of female patients (55.9%) was observed. Most patients were aged between 21 and 40 years (46.2%). Over half of the patients were outpatients (63.4%), with bipolar affective disorder being the most common diagnosis, accounting for 35.7% of ECT indications. Consent for ECT was obtained from all patients. Most treatments (85.2%) were conducted during the acute phase of illness. The average number of ECT sessions per patient was 5.4. All patients received anesthesia, and no deaths or severe complications related to ECT occurred. Monitoring cognitive effects and discharge criteria were the responsibility of the attending physician. Conclusions: The practice of ECT at IPUB-UFRJ adhered to both local and international guidelines. There has been a notable shift in the utilization patterns of ECT at the institute compared to previous years. Standardized monitoring of cognitive effects and discharge criteria remains essential.
- 3 March 2025
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 42 (3) , 170-174
Use of Electroconvulsive Therapy in a University Psychiatric Hospital in Brazil
Objectives: The aim of the study were to describe the practice of electroconvulsive therapy (ECT) at the Institute of Psychiatry (IPUB) of the Federal University of Rio de Janeiro (UFRJ) from 2015 to 2019 and to compare it with previous years at the same institute and with international practices. Methods: Sociodemographic and epidemiological data, along with information on ECT and anesthetic techniques, were collected from the medical records of all patients who received ECT at IPUB-UFRJ between 2015 and 2019. Results: A total of 238 patients underwent 4110 ECT sessions during the study period. A slight predominance of female patients (55.9%) was observed. Most patients were aged between 21 and 40 years (46.2%). Over half of the patients were outpatients (63.4%), with bipolar affective disorder being the most common diagnosis, accounting for 35.7% of ECT indications. Consent for ECT was obtained from all patients. Most treatments (85.2%) were conducted during the acute phase of illness. The average number of ECT sessions per patient was 5.4. All patients received anesthesia, and no deaths or severe complications related to ECT occurred. Monitoring cognitive effects and discharge criteria were the responsibility of the attending physician. Conclusions: The practice of ECT at IPUB-UFRJ adhered to both local and international guidelines. There has been a notable shift in the utilization patterns of ECT at the institute compared to previous years. Standardized monitoring of cognitive effects and discharge criteria remains essential.